4.3 Article

Are we ready to define cognitive worsening in MS? How different cutoffs detect future cognitive worsening after six years of follow-up

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse

Kyla A. McKay et al.

Summary: The study aimed to investigate the longitudinal relationship between relapses in multiple sclerosis (MS) and information processing efficiency. The findings revealed a decline in information processing efficiency during and after relapses, indicating that the effects of relapses on cognition are longer than previously thought. This highlights the importance of reducing relapse rates for preserving cognitive function.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

A much needed metric: Defining reliable and statistically meaningful change of the oral version Symbol Digit Modalities Test (SDMT)

L. B. Strober et al.

Summary: This study aims to develop methods for assessing statistically significant individual-level changes in SDMT. Results suggest that higher cut-points are needed to demonstrate statistically significant decline.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Article Clinical Neurology

Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?

Marcus W. Koch et al.

Summary: The study found that in patients with SPMS, SDMT scores steadily increased over a 2-year follow-up period, with overall few SDMT worsening events occurring throughout the trial. Additionally, PASAT scores exhibited a similar pattern of change as SDMT.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

A comparison of clinical outcomes in PPMS in the INFORMS original trial data set

Marcus W. Koch et al.

Summary: The study compared clinical outcome measures in patients with primary progressive multiple sclerosis, finding that EDSS and T25FW showed the most worsening events, with only a few patients worsening on NHPT, and PASAT scores slightly increased over time.

MULTIPLE SCLEROSIS JOURNAL (2021)

Article Clinical Neurology

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses

Ralph H. B. Benedict et al.

Summary: The study shows that siponimod has a significant benefit on cognitive processing speed in patients with secondary progressive multiple sclerosis. Siponimod-treated patients were at significantly lower risk for a >= 4-point decrease in SDMT score and had a significantly higher chance for a >= 4-point increase, which is considered clinically meaningful.

NEUROLOGY (2021)

Article Clinical Neurology

The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance

Joshua Sandry et al.

Summary: The SDMT not only measures information processing speed, but also encompasses memory, IPS, and rapid automatized naming, explaining its high sensitivity to cognitive changes in multiple sclerosis.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Article Clinical Neurology

Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis

Marcus W. Koch et al.

Summary: The study compared the frequency of progression and improvement events in SPMS trials using data from the placebo arms of two large RCTs. The EDSS showed the highest rates of improvement over time, with the smallest difference between progression and improvement rates, followed by the T25FW and 9HPT. The findings suggest random variation and measurement error in all investigated outcome measures, with the T25FW and 9HPT showing less than the more established outcome measure EDSS.

NEUROLOGY (2021)

Article Clinical Neurology

Cognitive trajectories in relapsing-remitting multiple sclerosis: A longitudinal 6-year study

Alfredo Damasceno et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Exploring the performance of outcome measures in MS for predicting cognitive and clinical progression in the following years

Alfredo Damasceno et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Clinical Neurology

No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy

Alfredo Damasceno et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Article Clinical Neurology

No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy

Alfredo Damasceno et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Article Clinical Neurology

Defining reliable disability outcomes in multiple sclerosis

Tomas Kalincik et al.

Article Clinical Neurology

Characterizing cognitive function during relapse in multiple sclerosis

Ralph H. B. Benedict et al.

MULTIPLE SCLEROSIS JOURNAL (2014)

Article Psychology, Clinical

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline

Sarah A. Morrow et al.

CLINICAL NEUROPSYCHOLOGIST (2010)

Article Clinical Neurology

Reliability, practice effects, and change indices for Rao's brief repeatable battery

Emilio Portaccio et al.

MULTIPLE SCLEROSIS JOURNAL (2010)

Article Psychology, Clinical

THE PREDICTION OF CHANGE: NORMATIVE NEUROPSYCHOLOGICAL TRAJECTORIES

Deborah K. Attix et al.

CLINICAL NEUROPSYCHOLOGIST (2009)